Approval · Notice of Compliance 36514 · 2025
ACID CONTROLLER MAXIMUM STRENGTH: Notice of Compliance 36514
Issued December 10, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 36514
- Date
- December 10, 2025
- Company
- Angita Pharma Inc.Boucherville, Quebec, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Update to Product Monograph (to align with CRP approved PM). Product Monograph reformatted to the Master Template
- Canadian reference product
- MAXIMUM STRENGTH PEPCID AC (McNeil Consumer Healthcare, division of Johnson & Johnson Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ACID CONTROLLER MAXIMUM STRENGTH | Not yet assigned | — |
Medicinal ingredients
- FAMOTIDINE 20 MG per TAB